Houlston R S, Bourne T H, Collins W P, Whitehead M I, Campbell S, Slack J
Department of Clinical Genetics, Royal Free Hospital and School of Medicine, London, UK.
Hum Hered. 1993 Mar-Apr;43(2):111-5. doi: 10.1159/000154126.
The risk of ovarian and other cancers was assessed in first-degree relatives of patients with ovarian cancer from an analysis of 391 pedigrees. Overall there was a significant increase in the risk of ovarian cancer (4.5-fold; p < 0.001). The risks were 14.2- (p < 0.001), 5.2- (p < 0.001) and 3.7-fold (p < 0.001) for relatives of patients diagnosed before 45, between 45 and 54 and after the age of 55, respectively. There was no significant increase in the risk of cancers of the uterus, stomach, lung, colorectum or prostate. There was, however, an overall increase in the risk of breast cancer (1.3-fold; p < 0.05). The risk was highest for those relatives of patients diagnosed with ovarian cancer before the age of 55 (2.2-fold; p < 0.01). These results support the role of genetic factors in the aetiology of ovarian cancer and provide further evidence for the existence of a breast-ovarian family cancer syndrome, which may result from the pleiotropic effects of the same gene in some families.
通过对391个家系的分析,评估了卵巢癌患者一级亲属患卵巢癌及其他癌症的风险。总体而言,卵巢癌风险显著增加(4.5倍;p<0.001)。对于在45岁之前、45至54岁之间以及55岁之后被诊断出卵巢癌患者的亲属,其风险分别为14.2倍(p<0.001)、5.2倍(p<0.001)和3.7倍(p<0.001)。子宫、胃、肺、结肠直肠癌或前列腺癌的风险没有显著增加。然而,乳腺癌风险总体有所增加(1.3倍;p<0.05)。对于在55岁之前被诊断出卵巢癌患者的亲属,风险最高(2.2倍;p<0.01)。这些结果支持遗传因素在卵巢癌病因学中的作用,并为存在乳腺-卵巢家族性癌症综合征提供了进一步证据,在某些家族中这可能是同一基因的多效性作用导致的。